Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

National Alliance On Mental Illness Observes Minority Mental Health Awareness Month
The National Alliance on Mental Illness (NAMI) reminds Americans that July is Bebe Moore Campbell National Minority Mental Health Awareness Month, a time for public education about serious mental illness in diverse communities.

Smokefree Innotec, Inc. Addresses FDA Concerns About Electronic Cigarettes
Smokefree Innotec, Inc. (Pink Sheets: SFIO) issued a statement referring to articles in USA Today and The New York Times of Wednesday, July 22, and Thursday, July 23rd, regarding the FDA taking aim at electronic cigarettes. The national dailies stated that tests show that certain e-cigarettes contain "known carcinogens and toxic chemicals," including diethylene-glycol (an ingredient used in antifreeze, printing ink, brake fluid and glue) and nitrosamine (which is used in rubber products, the tobacco industry, and - less concentrated - in beer and fish-products).
News of the day
Cancer Therapeutics, Inc.'s Partner NanoTherapies, Inc. Utilizes Revolutionary Solution For Disrupting And Treating Cancer
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced its new partner, NanoTherapies, Inc., is utilizing calcium phosphate nanoparticles to detect and treat cancer. These particles are about 350 times smaller than a human cell while providing both a safe and effective way to transport drugs and imaging materials into diseased cells.
Cardiovascular

Patient Recall Rates May Be Decreased By Digital Mammography Plus Digital Breast Tomosynthesis

Nationally, about ten percent of women in the US are recalled for a second mammogram after an abnormality is detected on the first one - for most women this can be very stressful. However the use of digital breast tomosynthesis and full-field digital mammography combined may be associated with a substantial decrease in recall rate, according to a study performed at UPMC in Pittsburgh, PA. Some researchers believe that digital breast tomosynthesis depicts the breast tissue in a way which may allow radiologists to identify some tumors which could be missed with standard two-dimensional mammography. The study included 125 patients that were evaluated using a combined method of digital breast tomosynthesis and standard digital mammography. "The use of digital breast tomosynthesis and full-field digital mammography (FFDM) was associated with a 30% reduction in recall rate for cancer-free examinations that would have led to recall if FFDM had been used alone," said Jules H. Sumkin, MD, one of the authors of the study. "Patient recalls are problematic at multiple levels. Patients pay an emotional price and it is a sheer inconvenience having to go back for a second appointment. It is also problematic for imaging facilities because they are faced with the high cost of res required for the recalls," he said. "We are confident that recall rates could be decreased by adding breast tomosynthesis to FFDM," said Dr. Sumkin. Digital breast tomosynthesis is not yet FDA approved. This study appears in the August issue of the American Journal of Roentgenology. Click here for abstract. Heather Curry American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009